Cornerstone Wealth Management LLC Raises Position in Sabra Healthcare REIT, Inc. $SBRA

Cornerstone Wealth Management LLC lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 81.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 72,331 shares of the real estate investment trust’s stock after acquiring an additional 32,550 shares during the quarter. Cornerstone Wealth Management LLC’s holdings in Sabra Healthcare REIT were worth $1,370,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after buying an additional 481,231 shares during the period. Principal Financial Group Inc. boosted its position in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after buying an additional 4,431,897 shares during the period. Bank of America Corp DE boosted its position in shares of Sabra Healthcare REIT by 9.4% in the third quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after buying an additional 447,528 shares during the period. Northern Trust Corp boosted its position in shares of Sabra Healthcare REIT by 1.1% in the third quarter. Northern Trust Corp now owns 3,930,245 shares of the real estate investment trust’s stock worth $73,260,000 after buying an additional 43,927 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Sabra Healthcare REIT by 33.7% in the third quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock worth $66,904,000 after buying an additional 903,841 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on SBRA shares. Truist Financial increased their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Wells Fargo & Company increased their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, March 26th. Citigroup increased their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Sunday, May 10th. Finally, Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a report on Friday, May 1st. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.20.

Sabra Healthcare REIT Trading Down 2.5%

Shares of SBRA opened at $20.67 on Friday. The company has a market capitalization of $5.21 billion, a P/E ratio of 32.81, a P/E/G ratio of 1.65 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a one year low of $17.08 and a one year high of $21.28. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The stock has a 50-day moving average price of $20.28 and a 200 day moving average price of $19.52.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. The firm had revenue of $221.75 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.